Cognitive Enhancement Pharmacologic, Environmental and Genetic Factors
Coordonnateurs : Knafo Shira, Venero César
Cognitive Enhancement: Pharmacologic, Environmental and Genetic Factors addresses the gap that exists in research on the topic, gathering multidisciplinary knowledge and tools that help the reader understand the basics of cognitive enhancement. It also provides assistance in designing procedures and pharmacological approaches to further the use of novel cognitive enhancers, a field that offers potential benefit to a variety of populations, including those with neurologic and psychiatric disorders, mild aging-related cognitive impairment, and those who want to improve intellectual performance.
The text builds on our knowledge of the molecular/cellular basis of cognitive function, offering the technological developments that may soon enhance cognition. Separate sections cover enhancement drugs, environmental conditions, and genetic factors in terms of both human and animal studies, including both healthy/young and aging/diseased individuals.
1. What Is Cognitive Enhancement?
2. Signaling Pathways Involved in Cognitive Enhancement
3. Molecular Mechanisms of Drug-Induced Cognitive Enhancement
4. Role of Environment, Epigenetics and Synapses in Cognitive Enhancement
5. Transgenic Mice with Enhanced Cognition
6. The Use of Viral Vectors to Enhance Cognition
7. Advancing Fear Memory Research with Optogenetics
8. Can Stem Cells be used to Enhance Cognition?
9. Alzheimer's Disease and Mechanism-Based Attempts to Enhance Cognition
10. Pharmacological treatment of cognitive dysfunction in neuropsychiatric disorders
11. Cognitive Enhancement in Humans
12. The Use of Transcranial Direct Current Stimulation for Cognitive Enhancement
13. Cognitive Enhancement: Ethical Considerations and a Look into the Future
Associate Professor, Department of Psychopharmacology at the Universidad de Educación a Distancia in Spain and is Director of the Lab for Neurobiology of Stress and Neurodegenerative Diseases. He has authored two books on psychopharmacology and memory work. He co-chaired the “Cognitive Enhancement in Health and Disease symposium at the 2012 Federation for European Neuroscience annual meeting.
- Provides a multidisciplinary knowledge, enabling a further understanding of cognitive enhancement
- Offers coverage of the pharmacologic, environmental, and genetic factors relevant to the topic
- Discusses cognitive enhancement from the perspective of both healthy and diseased or aging populations
- Topics are discussed in terms of both human and animal studies
Date de parution : 01-2015
Ouvrage de 392 p.
15x22.8 cm
Thèmes de Cognitive Enhancement :
Mots-clés :
ADHD; AMPA receptors; Adeno-associated virus; Alzheimer's disease; Ampakines; Amphetamines; Amygdala; Apolipoprotein E; Attention; Behavior; Bipolar disorder; Brain power; Brain stimulation; Brain training; Brain-derived neurotrophic factor (BDNF); Bryostatin; Caffeine; Cheating; Cognition; Cognitive enhancement; Cost-benefit; Dendritic spine; Enhancement; Ephrin; Epigenetics; Ethical and regulatory issues; Exercise; FGL; Fear; Gene therapy; Ghrelin; Glucose; Hippocampus; Insulin; LTP; Learning; Life style; Long-term potentiation (LTP); Major depression; Meditation; Memory; Methylphenidate; Mnemonics; Modafinil; NCAM PSA; NMDA receptors; Neural stem cells; Neurogenesis; Neuroplasticity; Neurosteroids; Neurostimulation devices; Neurotrophic factors; Neurotrophins; Nootropics; Optimization; Optogenetics; PTSD; Protein kinase C; Rho GTPase; Schemas; Schizophrenia; Sleep; Stimulant drugs; Stress; Synapse remodeling; Synaptic plasticity; Technology; Therapy; Transplantation; Video games; tDCS
